Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 13Carcinoma, Hepatocellular 7Carcinoma, Renal Cell 4Lymphoma 3Endometrial Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Lymphoma, Non-Hodgkin 2Liver Neoplasms 2Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1

Interventions

tremelimumab 3durvalumab 3Ipilimumab 3pembrolizumab 2Nivolumab 2Carboplatin 2poly ICLC 1osimertinib 1lenvatinib 1cemiplimab 1Vascular Endothelial Growth Factor A 1Vaccination 1Peptides 1Pemetrexed 1Paclitaxel 1Monophenol Monooxygenase 1Melphalan 1Docetaxel 1Axitinib 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diabetes Mellitus, Insulin-Dependent, 12 × lenvatinib × Clear all
NCT04522323 2025-07-25

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

MedImmune LLC

Phase 1 Active not recruiting
67 enrolled
Genitourinary

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡